DP
Devang Patel
About Devang Patel
Data last updated:
Devang Patel is a Director at Biovant Pharma India Private Limited (since 2022) and Director at Kkallium Pharma Private Limited (since 2023). The companies operate in Trading and Paper. The largest current company by reported revenue is Biovant Pharma India Private Limited at ₹1.53 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 21 Mar 2022 | 2021 | ₹1.53 Cr (FY 2024) | Active | |
| Director | 22 Aug 2023 | 2023 | Active |
Board colleagues of Devang Patel
| Name | DIN | Company | Designation |
|---|---|---|---|
| Dhanjibhai Vora | 09442081 | Biovant Pharma India Private Limited | Director |
| Joy Hareshkumar Patel | 10289272 | Kkallium Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Devang Patel
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Devang Patel
Devang Patel currently holds 2 directorships: Biovant Pharma India Private Limited (Director, since 21 Mar 2022, revenue ₹1.53 Cr (FY 2024)); Kkallium Pharma Private Limited (Director, since 22 Aug 2023).
Devang Patel was first appointed on 21 Mar 2022 as Director at Biovant Pharma India Private Limited. The most recent appointment on record is 22 Aug 2023 at Kkallium Pharma Private Limited.
The current boards of Devang Patel's companies include Dhanjibhai Vora (Biovant Pharma India Private Limited), Joy Hareshkumar Patel (Kkallium Pharma Private Limited).